Stimulated calcitonin cut-offs by different tests

Area of Science:

• Endocrinology
• Oncology
• Medical Diagnostics

Background:

• Medullary thyroid cancer (MTC) is aggressive, particularly when diagnosed late.
• Early MTC diagnosis relies on RET genetic testing and calcitonin (Ct) measurement.
• Basal Ct measurements can yield false positives, necessitating provocative testing.

Purpose of the Study:

• To review methods for stimulating calcitonin (Ct) levels.
• To discuss cut-offs for identifying C-cell hyperplasia/neoplasia.
• To evaluate calcium (Ca) stimulation as a diagnostic tool for MTC.

Main Methods:

• Review of studies on Ct stimulation tests, focusing on calcium (Ca) stimulation.
• Analysis of Ca test protocols (2.3-2.5 mg/kg elemental Ca).
• Discussion of proposed gender-related cut-offs for the Ca test.

Main Results:

• Calcium (Ca) stimulation is a potent and accurate method for Ct testing.
• Ca stimulation is a viable, cost-effective alternative to pentagastrin.
• Preliminary gender-related cut-offs for the Ca test have been proposed.

Conclusions:

• Calcium (Ca) stimulation is recommended for Ct testing in medullary thyroid cancer (MTC) diagnosis and follow-up.
• The Ca test is preferred due to availability, low cost, and minimal side effects.
• Further studies are needed to refine Ca test cut-offs.